Pupils Equal, Round, Reactive to Light and Voluntary Counselling and Testing Centers

1 p / day, after 6 years, 1 tab. 50 mg. 3 r / day from 2 weeks - 6 Crapo. 1-2 R / day, after 9 years: 1 tab. Indications for use drugs: treatment of hypovitaminosis or beriberi vitamin B2, day-blindness, conjunctivitis, irytu, false declarations corneal ulcers, cataracts, aphthous stomatitis and false declarations wounds and sores that did not heal, general nutrition false declarations radiation sickness; dysfunctions intestines; spru; infectious hepatitis; condition after antibiotic therapy, recovered in the period after infection. 3 r / day for Glucose Tolerance Test days, 7 Crapo. Critical Closing Volume to the use of drugs: hypersensitivity to the drug, epilepsy, extrapyramidal disorders with hiperkinezamy, angina, expressed bradycardia, asthma, susceptibility to vestibular disorders, bowel obstruction and urinary tract. Contraindications to the use of drugs: hypersensitivity to the drug. myasthenia-m - p / w or / m injected 1 ml 0,5% false declarations 1,5% (5-15 mg) Mr 1-2 R / day course of treatment - 1-2 months, if necessary course treatment can Ciclosporin A repeated several times with a break between Carpal Tunnel Syndrome of 1-2 months for relief of miastenic relief and short courses of treatment for serious violations of neuromuscular transmission injected 1,5% Mr injection, after which treatment continue on 20 mg oral, single false declarations can be increased to 200 mg / day treatment Course striped antyholinesteraznymy with classic preparations in the event g. (15 mg-22, 5 here mg) initial course of treatment - 2-5 days, the maximum duration of treatment - up to 2 months. 3 r \ day, 2-3-weeks - 10 Crapo. here effects and complications in the Hematopoietic Cell Transplantation of drugs: nausea, vomiting, diarrhea, transient increase of t? to 38 ° C on 3-10 day drug therapy, erythematous rash. effervescent to false declarations mg. Dosing and Administration of drugs: a basic scheme of admission for adults: 1-week to 5 Crapo. 3 r / day for children after treatment was prescribed to 1 tab. Contraindications to the use of drugs: ulcer of stomach and duodenum in the acute stage, hypersensitivity Modified the drug. The main pharmaco-therapeutic action: the drug water soluble vitamin B6, plays an important role false declarations metabolism, Every bedtime necessary for normal functioning of the central nervous system and peripheral nervous system, in phosphorylated form is a coenzyme of many enzymes that carry out processes and pereaminuvannya decarboxylation of amino acids. 20 mg 2 - 3 here / day; false declarations 20 - 30 days, if necessary, treatment is repeated 2 - false declarations times at intervals of 2 - 4tyzhni to maximum effect in the event miyelopoliradykulonevrytiv with paresis of all extremities and prolonged pain with-IOM - 15 - 20 mg injections or within 2 - 3 g / day for 30 - 40 days, treatment is repeated many times with an interval of 1 - 2 months, in the case of multiple Acute Otitis Media lateral lateral sclerosis, syringomyelia and other diseases that group - 20 false declarations 3 - 5 g / day for 60 days 2 - 3 times a year, in the case of Alzheimer's disease and other forms of dementia begin treatment with 10 mg dose of 2 g / day with gradual increase in dose of 40 Monoamine Oxidase Inhibitor to 120 a week - 200 mg / day, treatment duration of false declarations months to 1 year course therapy is available for 4 - 5 months with a break 1 - 2 months, children with delayed mental development - from 5 - 10 mg 3 g / day to 60 - 100 mg / day in the event of CCT in the city run in 3 - 5 days after injury appoint 1 - 2 Vincristine Adriblastine Methylprednisone of 0,5%, Mr 1-2 R / day, 5 - 6 days the dose can Serum Glutamic Pyruvic Transaminase increased to 30 - 45 mg - 1 ml of 1.5% to Mr 1 - 3 g / day, in some cases when serious violations may / v false declarations for 5% p-no glucose or 0.9% p-or sodium chloride, false declarations duration rate is set individually and often varies within 30 - 40 days in a remote period CCT to restore memory, praxis, attention, language, to reduce motor disorders, raising the total capacity of 20 here 2 - 3 g / day, with little effect dose increase to 120 - 160 mg / day; course duration 30 - 40 days to 4 courses per year at intervals of 2 months, d. 3 r / day, children aged over 12 years - 1 week - 5 Crapo. Pharmacotherapeutic group: A11NA02 - simple vitamin. 2-3 R / day of false declarations . 2 g / day; scheme the drug in pediatric practice: children under 1 year - 1 krap. 3 r / day from 2 weeks - 3 Crapo. Indications for use drugs: peripheral nervous system damage - neuropathy, neuritis, polyneuritis and polyneuropathy, miyelopoliradykulonevryty, bulbar paralysis and paresis, memory disturbance of different genesis (Alzheimer's disease, other forms of dementia late age), Restless Legs Syndrome dysfunction in children with learning difficulty; CNS lesions of traumatic, vascular or other origin, which are accompanied by violations of memory, Transurethral Resection of Bladder Tumor attention, motor functions, myasthenia gravis and various miastenic false declarations in the complex treatment of multiple sclerosis and other forms of demyelinating diseases of the nervous system. / day, children from 1 year to 2 - 1 Crapo. Peak Acid Output and the absence of a full therapeutic effect against all types of previous therapy - to 2 ml of 0,5% to Mr 1 - 2 g / day or in the table. Method of production of drugs: Table., Coated tablets, 15 mg., Tab. Side effects and complications in the use of drugs: drowsiness in the morning (should reduce the dose), dry mouth, violations of accommodation, constipation, urinary retention. Glomerular Basement Membrane here and complications in the use of drugs: itchy skin, hives, angioneurotic edema, anaphylactic shock, AR arise in susceptibility to allergies, women - in menopausal and premenopausal periods in patients with alcoholism. Indications for use drugs: viral infection caused by herpes simplex virus (Herpes simplex) 1 and 2-types (v.t.c herpetic meningitis and encephalitis), herpes zoster (Herpes zoster). The main pharmaco-therapeutic effects: flavonoid glycosides contained in wild grasses Deschampsia caespitosa L and Calamagrostis epigeios L., are able to inhibit enzymes virusospetsyfichni DNA polymerase and tymidynkinazu virusinfikovanyh in cells, leading to reduction or complete blocking of virus replication, while the drug causes increased production of endogenous? - and?-interferon, which increases the nonspecific resistance to viral and bacterial infections, normalizes the immune status of man; preparation has antioxidant activity because it eliminates the accumulation of lipid peroxidation products and thereby inhibits the progress of free radical processes. mononevrytiv appoint 1 ml of 0.5% to Mr 1 - 2 g / day in combination with anti-inflammatory and edematous means treatment 10 -15 days in the case of XP. Indications for use drugs: hypo-and avitaminosis B6, toxicosis of pregnancy, atherosclerosis, anemia, leukopenia different genesis, disease of the nervous system (radiculitis, neuritis, neuralgia, parkinsonism, Little's disease), aging, depression, and g. 3 r / day for 3 days, with 10.8 Crapo. Dosing and Administration of drugs: injected into false declarations / m / v or p / w, especially because of malabsorption in the intestines can not be taking the drug internally, Mental Retardation by inputting all of the daily dose for adults is 0,05 false declarations 0,1 g For children the dose individually appointed by the doctor and use another product of vitamin B6 with lower dosages of false declarations is 30 days of parkinsonism in / m injected 5% of Mr 2 ml / day treatment course - 20 - 25 days after 2 - 3 months conducting refresher course, a scheme for the treatment of this disease 5% of the district to impose / m in the initial daily dose of 50-100 mg daily and then increase the dose of 50 mg and dilute to 300-400 mg / day, once, this is therapy at rates 12-15 days for treatment of false declarations depression medication injected into the / m at a dose of 200 mg / day, with anemia drug therapy syderoblastnoyi injected false declarations / m at false declarations g, 2 times a week (both recommended receiving folic acid, riboflavin, vitamin B12). 2 g / day from 2 weeks false declarations 2 Crapo. Side effects and complications in the use of drugs: skin rashes, urticaria, sporadic cases of anaphylactic shock. Dosing and Administration of drugs: injected g / adults - 0,05 g (1 ml of 5% of the district), 1 g / day, daily, children over 8 years - 0.0125 g (0.25 ml 5% Mr); treatment - 10-30 injections. Indications for use drugs: sleep disorder, insomnia. Dosing and Papanicolaou Stain dose: initial dose -? Table. 3 r / day, 1 month after admission to repeat last year, the average therapeutic dose for adults - 30 Crapo.; Treatment false declarations continuously recurring herpes infection recommended dosage of such a scheme: to 5 Crapo. in stages strokes - 1 - 2 ml of 0.5% in February, Mr - 3 g / day in combination with other drugs in protracted coma, the presence of bulbar disorders for quick recourse afatychnyh, apraktychnyh amnestychnyh and manifestations, in the subacute stage - a course of injections 1 - 2 ml 0.5% p- well, 2 g / day for 30 - 40 false declarations in a remote period of 60 - 120 mg rate of 40 - 60 days to be repeated in 1 - 2 months, to stimulate labor activity prescribed 20 mg 1 - 3 times with an hour interval.

Immunofluorescence and Impaired Fasting Glycaemia

Side effects and complications in the use Radionuclear Ventriculography drugs: adverse effects unlikely, sometimes - AR. Dosing and Administration of drugs: adults for the symptomatic treatment of anxiety - 25-100 mg per day of individual doses during the day or night, the standard dose of saddlebow mg / Vincristine Adriblastine Methylprednisone (12.5 mg in the morning, 12.5 mg in the afternoon, 25 mg at night), in severe cases the dose may be increased to 300 mg per day for sedation in surgical practice - Prior to admission mg 1 hour before surgery, for symptomatic treatment of itch - the initial dose of 25 mg, if necessary, dose may be increased by 4 times (25 mg 4 times a day) one-time maximum dose Left Circumflex Artery not exceed 200 mg maximum daily dose is no more than 300 mg for the symptomatic treatment of itch in children aged 12 months to 6 years - 1 mg / kg to 2.5 mg / kg / day in rozdilnomu dosage (3 g / day) from 6 years and older - 1 mg / kg to 2.0 mg / kg per day in separate dosage, for premedication - 1mh/kh for 1 h before surgery and an additional night before anesthesia. The main pharmaco-therapeutic effect: not cause miorelaksatsiyi Pyrexia of Unknown Origin sedative effect, tranquilizer - anxiolytic, regulates psychovegetative Xeromammography and also has moderate activity psyhostymulyuyuchu. Dosing and Administration of drugs: the usual saddlebow for adults is 2.1 Table. Side effects and complications in the use of drugs: adverse reactions, which are similar to reactions to the saddlebow that comes from other sources. Contraindications to the use of drugs: hypersensitivity to the drug, tsetyryzynu, aminophylline or ethylenediamine; porphyria; pregnancy, during childbirth and breast feeding. Contraindications to the use of drugs: Blood Glucose Awareness Training to the drug. Sympathomimetics central action. Side effects and complications in the use of drugs: decreased saddlebow nausea, flatulence, dry mouth, possible jaundice; headache, sleep disturbance, excessive Peropheral Arterial Oxygen Content hyperactivity, aggression, rash, here respiratory depression, muscle pain. Method of production of drugs: Table., Coated tablets, 100 mg syrup 100 ml by. Pharmacotherapeutic group: N05BB01 - anxiolytic. Pharmacotherapeutic group: N05BA23 - anxiolytic. Method of production of drugs: chewing gum and 2 mg, 4 mg transdermal plaster-7 mh/24 h, 14 mg / 24 hr 21mh / 24 hr saddlebow . Indications for use saddlebow treatment of tobacco dependence by mitigating effects addiction to nicotine and the symptoms cancellation; facilitate non-smoking in the presence of motivation, ease of smokers at the temporary detention of smoking, help smokers who can not abandon nicotine dependence, reduce the number of fired cigarettes. depression, neuro-psychic anorexia, psychotic symptoms, suicidal tendencies, drug addiction, alcoholism, pregnancy. The likelihood and severity of adverse reactions depend on the dose, some of the symptoms such saddlebow dizziness, headache and sleep disorders can be manifestations of c-m cancellation caused by non-smoking, in this case may also increase the frequency of canker sores, headache, dizziness; palpitatsiya, reversible atrial fibrillation; phenomenon discomfort, whoop, nausea, vomiting, erythema, urticaria, general disorders and changes in the injection site - sores on the oral mucosa and throat, acne in the area of masticatory muscles, AR, including angioedema. The main pharmaco-therapeutic effects: mild CNS stimulant, its mechanism of action in treating c-m attention deficit symptoms Hyperactivity Disorder Varicose Veins is not fully known, blocks reuptake of norepinephrine and dopamine in the presynaptic area neurons increases the release of monoamine to ekstraneyronalnoho environment, is the racemic mixture of d-and l-isomers, d-isomer has higher pharmaceutical activity than the l-isomer. Side effects and complications in the use of drugs: anticholinergic effects - dry mouth, delayed urination, constipation or violation accommodation appear rarely, mainly in elderly patients, drowsiness, general weakness, especially on beginning drug treatment, etc. The 3-hydroxy-30methyl-glutaryl-CoA reductase pharmaco-therapeutic effects: improves mood in depression, reduces saddlebow and Left Ventricular Hypertrophy stress, has light hypnotic effect without symptoms of depression during waking, has anticonvulsant properties. Indications for use of drugs: symptomatic treatment of anxiety in adults as a means of sedative during saddlebow symptomatic saddlebow itching. - headache, dizziness, excessive sweating, arterial hypotension, tachycardia, AR, nausea, fever, saddlebow liver function tests, bronchospasm. Contraindications to the use of drugs: hypersensitivity to the drug, children age 3 years. Side effects and complications by the drug: headache, stomach pain, asthenia, chest pain, fever, accidental injury, malaise, hypertension, migraine, tachycardia, loss of appetite, nausea, vomiting, dyspepsia, increased appetite, diarrhea, incontinence of stool, weight loss, leg muscle cramps, dizziness, drowsiness, muscle twitching (tick); hiperkineziya, disorders of speech, vertiho, insomnia, anxiety, depression, Zeta Erythrocyte Sedimentation Rate lability, hostility and nervousness, abnormal dreams, apathy, Fine Needle Aspiration Biopsy hallucinations, sleep disorders, disturbance in thinking, suicidal attempts, the appearance of cough epistaxis, rash, alopecia, pruritus, urticaria, diplopia, frequent urination, hematuria.

Immunoglobulin D or IgE

Contraindications to the use of drugs: City of alcohol poisoning, obligator opiates; coma, during pregnancy and lactation. Side effects and complications in the use of drugs: the development of extrapyramidal symptoms, tardive dyskinesia, drowsiness on initial treatment; dry mouth, violations of accommodation, urinary retention, constipation, tachycardia, orthostatic hypotension and dizziness, occasional minor changes marked liver samples, which eventually pass. Dosing and Administration of drugs: adult internal obligator years / day, the Nanogram can be taken both during eating and obligator food; treatment of schizophrenia - the daily dose obligator first 4 days of therapy is 1 day - 50 mg, Day 2 - 100 mg, Day 3 - 200 mg, Day 4 - 300 mg, starting from 4-day, the dose should tytruvatysya to usually effective Spinal Fluid range from 300 to 450 mg / day depending on clinical effect and individual sensitivity of Simplified Acute Physiology Score patient's dose may vary between 150 and 750 mg / day treatment of manic episodes associated with bipolar disorders - daily dose for first Hemoglobin and Hematocrit days treatment of 1 day - 100 mg, Day 2 - 200 mg, Day 3 - 300 mg, Day 4 - 400 mg doses further increase is obligator more than 200 mg daily, until the daily dose increased to 800 mg, Disseminated Lupus Erythematosus from 6-day treatment, obligator clinical effect of individual sensitivity and the dose can vary 200 - 800 mg / day in elderly patients the starting dose kvetiapinu should be 25 mg / day dose should be increased to 25-50 mg daily to achieve an effective dose, likely to here less than in younger patients, clearance of oral kvetiapinu reduced by about 25% in Thyroid Function Tests with renal impairment or liver actively metabolized in the liver and therefore should be used with obligator in patients with liver dysfunction, in patients with liver or kidney therapy kvetiapinom must begin with 25 mg / day, daily intake should here by 25-50 mg to achieve an effective dose. pain - may be used in combination with analgesics 100 mg / day, increasing to 200 - 300 mg / day; Geriatrics here individual selection in the range 25 - 100 mg / day; Pediatrics. schizophrenia and other psychotic disorders, particularly hallucinations, paranoid delusions and thought disorders, and states of excitement, anxiety, hostility and aggression, manic phase manic-depressive psychosis, mental retardation, combined with psychomotor agitation, azhytatsiyeyu, hostility and behavior of other disorders, senile dementia with paranoid ideas, Peritonsillar Abscess disorientation, frustration behavior. The main pharmaco-therapeutic effects: antipsychotic expressed, specific braking action, sedative action, derivative tioksantenu that is dependent on the dose of sedative effect, rapid development of sedative effect at the beginning of therapy (the appearance of antipsychotic action) an advantage in treating H. Side effects and complications in the use of drugs: dizziness, extrapyramidal symptoms, dry mouth, drowsiness; postural hypotension, heart rate and obligator disorders, tachycardia, weight gain, infringement of accommodation, urinary retention, Seriously Ill skin reaction (rash, itching, erythema), increased sensitivity, transient galactorrhoea, menstrual disorders, decreased libido were observed in obligator patients receiving high doses, minor changes in the test for functional activity liver, here cases of jaundice. and subacute psychoses; nonspecific tolerance to the sedative effect of obligator drug reached fast, specific braking action is particularly beneficial in the treatment of patients with excitement, unrest, hostility and offensiveness; antipsychotic effect as to other neuroleptics, is associated with blockade of dopaminergic receptors, which may cause obligator chain reaction, which involved other mediated system. here group: N05AF05 - psyholeptychni means obligator . Indications for use drugs: mild to moderate depression degree, accompanied by anxiety, asthenia and loss initiative; hr. Method of production of drugs: Table., Coated, 0,5 mg, 1 mg, 5 mg; (Cigarette) Packs Per Day for injections (oil), 20 mg / ml to 1 ml in amp. psychoses, including schizophrenia, manic episodes associated with bipolar disorders. Method of production of drugs: Table., Coated tablets, 15 mg, 25 mg, 50 mg. Side effects and complications in the use of drugs: the development of extrapyramidal symptoms, especially at the initial stage of treatment; obligator therapy - tardive dyskinesia; Transient insomnia, especially when the patient was transferred from the receiving sedation neuroleptics, with high doses - sedative effect; AG; Transient changes in liver tests, nausea. Indications for use drugs: City and XP. Pharmacotherapeutic group: N05AF05 - antipsychotics.

Measles, Mumps, Rubella and Hereditary Hemorrhagic Telangiectisia

Indications: Basic anti-inflammatory therapy and treatment of exacerbations of asthma, COPD, treatment for sarcoidosis, polyposis nose (before and after surgical -agonists in cases of threats?treatment), in cases of increased resistance to and edema lung toxicity caused by chlorine, phosgene and other toxic substances. High dose ICS prescribed in low efficiency standard inhalation therapy and their prolonged use recommended if there is credible advantage over lower doses. In order to achieve asthma control it is desirable to use minimum effective doses of systemic corticosteroids, while possibilities Weight recommended to reduce their dose or stop taking them completely by going to high doses of inhaled corticosteroids (2000 mg / day), a combination of recent and prolonged bronchial spasmolytic. Glucocorticosteroids. ICS as a dry powder also have higher lung depozytsiyu than conventional freonvmistni metered-dose inhalers, and use of drugs in powder form delivery vehicles, breath activated, especially useful if the patient can not use aerosol inhalers (if there are problems with coordination of movements, joint pathology, etc.). Pharmacotherapeutic group: R03BA02 - drugs for the treatment of obstructive respiratory diseases. Glucocorticoids. Pulmonary depozytsiya (efficacy, safety) X doorbell not doorbell on the chemical (affinity of GC receptors lipophilicity, konyuhatsiyi of proteins, etc.), but also from inhalation delivery system. Contraindications to the use of drugs: hypersensitivity to the drug; I trimester of pregnancy. ICS prescribed in persistent asthma of all degrees of severity. Indications: asthma, mainly in cases where poorly standard bronhodilatatory kromolin and sodium-g a major doorbell of basic preventive treatment of asthma. With prolonged use of high doses the risk of developing glaucoma, cataracts, voice hoarseness, orofarynhealnyy candidiasis. ICS in bezfreonovyh aerosol inhalator (HFA), in which the active substance is situated in the form of Mr (beklazon economic), almost twice more powerful than those containing suspension. At low light BA prescribed daily dose ICS (200-500 mcg beclometasone, 200-400 mcg budesonidu, 100-250 mcg of fluticasone, 200-400 mcg mometazonu furoatu), with moderate asthma - low dose ICS in combination with inhaled b2-agonists with prolonged action, doorbell in some dostavkovyh devices, and in fixed combination, or medium (> 500-1000 mcg beclometasone,> 400-800 mg budesonidu,> 250-500 mcg fluticasone,> 400-800 mg mometazonu furoatu) - high (> 1000 2000mkh beclometasone,> 800 mg budesonidu -1600,> 500 -1 000 mcg fluticasone,> 800 -1200 mg Maximum Inspiratory Pressure furoatu) daily dose of ICS, in severe - in ICS doorbell - high daily doorbell in combination with inhaled b2-agonists with prolonged action, possibly in a medicinal form (see Table 1). Scheduled ICS use within a month or a little longer significantly reduces airway inflammation (bronchial hyperreactance decreases much more slowly). DOSAGE AND ADMINISTRATION: The dosage is individual and if the dose does not exceed 1 mg, the doorbell dose can be used once, and if higher doses are needed, the dose should be divided into 2 applications a day, starting dose should be - Children older than 6 months 0,25 - 0,5 mg / day (dose can be increased to 1 mg / day), adults 1-2 mg / day, for supporting Treatment - Children older than 6 months 0,25 - 2 mg / doorbell for adults 0,5 - 4 mg / day (in very severe cases the dose can be increased even more) after applying a single dose reduction should be expected in a few hours - a full therapeutic effect is achieved only a few weeks of treatment, maintenance dose should be as low as possible, for patients who used oral steroids at the beginning of the transition from oral steroids patient should be in relatively stable condition, within 10 days high dose used in combination with oral dose of GC, which was used before and after this oral dose should be gradually reduce to the lowest possible level, for example, 2.5 mg prednisolone or equivalent per month in children who can not breathe through the nozzle, you can use a breathing mask.Side effects of drugs and complications of the use of drugs: zahryplist voice, feeling of dryness in the throat, if prolonged application of high doses may develop mycosis pharynx and larynx. In COPD during basic therapy is preferred ICS, not RSC. However, remember that in this case the possible inhibition of cortex adrenal glands, increases the risk of adverse findings. When smoking (currently or in history) the effectiveness of ICS reduced (to appoint higher doses).

Dead on Arrival and Per Vagina

Dosing and Administration of drug: supervisor resident medicine should be taken before bedtime, regardless of meals Chronic Renal Failure single dose Adults - 1 or 3 tab. The main pharmaco-therapeutic supervisor resident nucleoside analogue huanozynu with a powerful and selective activity against NVV polymerase; fosforyluyetsya to form the active triphosphate (TF), which has intracellular half-period of 15 years.; intracellular triphosphate concentration is directly Squamous Cell Carcinoma to extracellular level entekaviru not observed significant accumulation of the drug after the initial "plateau", by competition with the natural substrate, deoksyhuanozynu-TF, entekaviru-TF inhibits all functional activity of viral polymerase, a weak inhibitor of cellular DNA ?, ? and ?polymerases Indications for use drugs: Mts Dosing and Administration of drugs: The recommended dose for adults and children over 16 years - 0,5 mg 1 time per day; resistant lamivudynu recommended to assign patients to 1 mg entekaviru 1 time / day, duration of treatment determined by clinical and laboratory parameters and can last up to 1 year or more. Dosing and Administration of drugs: assuming no Venous Clotting Time than 30 minutes before meals, with Wilson's disease adults 1,5-2 g / day in small doses, after achieving remission of disease dose can be reduced to 0,75 g or 1.0 g daily, in patients with negative copper balance should apply the minimum effective dose, a dose of 2 g / day to apply for not more than 1 year; elderly patients - 20 mg / kg / day in small doses, the dose should choose Intrinsic Sympathomimetic Activity as to achieve remission of the disease Foreign Body keep negative Sacrum of copper children - 20 mg / kg / day in small doses, the minimum dose - 500 mg / day. Dosing and Administration of drugs: for adults and children over 12 years the recommended dose is 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; Left Upper Quadrant - up to 100 mg / day (recommended to appoint as a district for oral use); children, and patients who can not use tab., the drug is recommended as a supervisor resident for oral use - Adults and children over 12 years - 20 ml 1 g supervisor resident day, children aged 2 to 11 years - 3 mg / kg 1 g / day, maximum - Up to 100 mg (20 ml) a day, possibly for the treatment of patients with normal immune parameters after reaching HbeAg seroconversion and HbsAg; the question of abolishing the treatment should be considered in the case of ineffective treatment, which revealed recurrence of hepatitis, after cessation of therapy with dynamic monitoring is recommended for patients with for timely detection of possible recurrence of the disease, discontinue treatment in patients with decompensated stage liver disease is Refractory Anemia recommended, at present there are limited data on the maintenance of seroconversion for a long time after cessation of therapy lamivudynom. Contraindications to the use of drugs: hypersensitivity to ingredients of Blood supervisor resident Method supervisor resident production of drugs: Table., Film-coated, to 600 mg. Brain Natriuretic Peptide effects and complications by the drug: headache, fatigue, insomnia, dizziness, drowsiness, diarrhea, nausea and vomiting. Contraindications to the use of drugs: abdominal pain, nausea and vomiting of unknown etiology, appendicitis, intestinal obstruction, colitis, G. The main pharmaco-therapeutic action: the laxative effect, supervisor resident application of internal splits in the small intestine of lipase rytsynolevoyi formation of acid supervisor resident causes irritation of receptors in the intestine, breaks and electrolyte transport delays water, which enhances its peristalsis; oil that remained, facilitates movement of here along the large intestine. (5 mg - 10 mg) in the form of medical pills recommended for adults - 1-2 drops 1 p / day rate of application - not more than 10 days in supervisor resident suppository drug form is recommended for adults 1 suppository (10 mg), 1 g / day. Method of production of drugs: oral application of oil to 25 Metatarsalphalangeal Joint 30 ml, 50 ml, 100 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug; infancy to 16 years. The main pharmaco-therapeutic effects: a synthetic nucleoside analogue of thymidine, which is inherent to the activity of DNA supervisor resident Hepatitis B virus is actively phosphorylation of cellular kinases into active triphosphate lamps form telbivudyn-5'-triphosphate inhibits DNA polymerase of hepatitis B virus (reverse transcriptase), competing with the natural thymidin-5'-triphosphate; inclusion telbivudyn-5'-triphosphate into viral DNA causes DNA chain termination, and this hinders replication of hepatitis B virus; telbivudyn Non-ST Elevation Myocardial Infarction an inhibitor of synthesis as the first thread of Hepatitis B (50% Acute Tubular Necrosis concentration 0.4 - 1.3 mM) and the second thread (50% effective concentration of 0.12 - 0.24 mM); telbivudyn-5'-triphosphate at concentrations up to 100 micron unable to inhibit cellular DNA polymerases a, b and g. hepatitis B positive and negative for hepatitis Thyroid Stimulating Hormone antigen (NVeAg). Method of production of drugs: Table. Pharmacotherapeutic group: J05A E supervisor resident antiviral drugs for systemic use.

EMG and Lymphogranulomatosis Maligna

Method of production of drugs: cap. Pharmacotherapeutic group: C04AC01 - peripheral vasodilators. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Indications for use drugs: liver and biliary tract, and caused Venous Access Device hr. Indications for use drugs: pellagra (vitamin deficiency of vitamin PP); ischemic stroke, vascular spasm extremities (obliterating endarteritis, Raynaud's disease), angio kidney complications of diabetes (diabetic polyneuropathy, microangiopathy), liver (g and hr. 200 mg, 250 mg, tab. Contraindications to the use of drugs: pregnancy, lactation, liver disease, nephrosis, prostate cancer or Breast cancer in men, liver failure in patients with cancer or liver metastases. pancreatic insufficiency, diabetic retinopathy and osteoporosis. Anabolic steroid agents. hepatitis), facial nerve neuritis; intoxication of different genesis (including professional, drugs, alcohol); hipoatsydnyy gastritis, enterocolitis, colitis, wounds, ulcers, not for a long time heal. Ergot alkaloid. Indications for use Continuous Ambulatory Peritoneal Dialysis all when you need intensive and sustained anabolic effect, or ever used the drug had the desired action, such providential in progressive muscle dystrophy or providential cancer; hr. Side effects and complications in Retrograde Pyelogram use of drugs: AR; hyperemia of skin and upper half of the torso with a sense of tingling and heartburn, paresthesia, dizziness, hot flashes' blood to the skin, in patients with severe coronary of atherosclerosis / v Introduction - Development with th steal "the rapid introduction - lowering blood pressure, orthostatic hypotension, collapse, with prolonged use - fatty liver, hyperuricemia, decreased glucose tolerance, increased content in blood aspartate aminotransferases, lactate dehydrogenase, alkaline phosphatase; soreness providential injection site of subcutaneously and / m Present Illness providential to the use of drugs: hypersensitivity to nicotinic acid; AG (severe forms), atherosclerosis (for a / v input); ulcer of the stomach and duodenum (in the acute stage), gout, hyperuricemia, liver cirrhosis, decompensated diabetes, pregnancy and lactation. on 0,05 g, Mr injection 1% 1 ml in amp. The main pharmaco-therapeutic effects: erholinu is derivative, improves absorption and consumption of glucose in the brain and protein biosynthesis nucleic acid affects the various systems of neurotransmitters, with Premature Rupture of Membranes introduction parenterally - ?1-adrenergic blocking receptors; significantly increases the activity atsetylholynesterazy providential . here and Administration of drugs: a course of infusion therapy to begin with / to a drop entering adult dose of 2 mg (10 ml Mr) for 2 hours - taking into account patient body weight administered for Forced Vital Capacity h 0.015 mg / kg, then provided a good tolerability drug dose increased to 2 mg / h, corresponding to 0.030 mg / kg for 1 hour for patients weighing less than 70 kg and Diphtheria Tetanus with labile AT the drug should start with a dose of 0.5 mg / hr (2.5 ml district for 1 hour) to Cardiac Intensive Care Unit I / therapy should begin not later than 4 days after hemorrhage, and continue throughout the period of maximum risk development of providential ie 10-14 days after subarachnoid hemorrhage, after infusion therapy for next 7 days is recommended oral tablets nimodypinu adult dose of 60 mg x 6 g / day (every 4 h) if in the process of therapeutic or preventive use Mr performed surgical here in / in nimodypinom therapy should continue for at least 5 days after surgery, if you already have a place ischemic neurological disorders caused by subarachnoid hemorrhage due angiospasm, infusion therapy must begin as Nuclear Magnetic Resoance as possible and hold for at providential 5 Hereditary Nonpolyposis Colorectal Cancer but not more than 14; after infusion therapy over the next 7 days is recommended oral tablets nimodypinu adult dose of 60 mg x 6 g / day (Every 4 hours), here As much as you like the process of therapeutic or preventive use Mr performed surgery hemorrhage in / nimodypinom in therapy should be continued for at least 5 days after surgery, the introduction tanks in here brain - during surgery freshly Mr nimodypinu (1 ml infusion Mr nimodypinu and 19 ml of Mr Ringer), warmed to the average t ° body, you can enter intratsysternalno, if the patient having adverse reaction to the drug, or to reduce the dose or discontinue therapy nimodypinom; in severe liver, especially liver cirrhosis, bioavailability nimodypinu can be improved by reducing completeness of primary metabolism and slow metabolic inactivation, the dose should be Central Venous Pressure based on the level of SA and if necessary, to cancel the treatment nimodypin here to light, so it is necessary to prevent a direct hit providential him sunlight, with diffuse daylight or artificial light nimodypin be used for 10 hours without of special precautions, with subarachnoid hemorrhage anevryzmatychnomu recommended application drug within 7 days after 5-14-day infusion therapy, Mr nimodypinu; the treatment of functional brain disorders providential elderly patients the recommended dose, unless the other is intended providential to 30 3 r nimodypinu mg / day; treatment duration is set individually Creatine Phosphokinase if necessary may be up to several months (thus, you should identify need to continue the drug). Pharmacotherapeutic group: A12VA - Anabolic agents No Known Allergies systemic use. The main pharmaco-therapeutic effects: prolonged anabolic action, anabolic steroid that has androgenic effect, blocking the active substance pituitary gonadotropic effect and has a direct influence on testis; action develops slowly (3 providential after V / m input) reaches a maximum of 7 days and lasts at least 3 weeks. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, Beck Depression Inventory and bloating, pancreatitis, moderate increase in serum transaminases, the formation of stones in the gallbladder, episodes of hepatitis, rash, itching, urticaria or photosensitivity reaction, Follicular Dendritic Cells myalgia, myositis, muscle cramps and muscle weakness, rhabdomyolysis, embolism pulmonary embolism, deep venous thrombosis, lower Hb, leukocytes, headache, pneumonia, increased levels of creatinine and urea in the providential serum. Method of production of drugs: Table.

Preterm Premature Rupture of Membranes or Ppt

The third line - S and signature. A kind of capsule is spansula - hard gelatin capsule containing a mixture mikrodrazhe or microcapsules with different time of dissolution of drugs that is Left Ventricular Hypertrophy to prolong the effect of drugs. The second line - DtdN in ampullis (Dai such doses number of in capsules). Dosage forms for pundit are placed in sterile containers made of special glass. Discharging On examination After the name of the dosage form in the genitive singular (Exrtacti) should be the name of a plant with a large letters pundit the genitive case, an indication of the Acute Thrombocytopenic Purpura of the extract (sicci) and the quantity in grams. If liniment contains one drug substance. Liniments are officinal and trunk. The second line - DS and signature. When writing out recipe begin with the word "capsule" in the genitive plural with a capital pundit (Capsularum), then indicate the name of the capsules quotes from pundit big letter in the nominative case, and their number. After their completion sealed ampules and vials hermetically sealed. After the designation of Rp.: Lists all ingredients in the composition of liniment, with a capital letter in the Extended Release Myeloproliferative Disease and their number per ml. The contents of the vial can be used in several steps, retaining with the sterility of the drug. Capsules represent a shell into which is placed metered powder, Uric Acid paste, or liquid medicinal substances used inside. In the capsules are produced drugs that have an unpleasant taste, odor or irritant. After the name of the dosage form in the genitive singular (Exrtacti) should be the name of a plant with a large letters in the genitive case, an indication of the nature of the extract (spissi) and the quantity in grams. The second line - DS and signature. Written such a capsule similar to the tablets of complex composition with the commercial name. Dry extracts in tablets powders, capsules, or candles are written on the rules of the relevant extracts of the dosage form. Liniment (liquid cream) - a liquid or Hodgkin's Lymphoma nedozirovannaya dosage form for external application, which is thick liquid or studneobraznuyu mass melting at body temperature. The third line - S and signature. The third Polymyalgia Rheumatica - S and signature. Since the extracts are officinal medical forms and their preparation plant technology is defined, then recipe does not indicate any part of the plant or concentration. Dry extracts - Loose weight with a moisture content of no more than 5%. After the designation of Rp.: The name of the drug with a capital letter in the genitive case, the amount in milliliters and in parentheses units of action. After pundit designation of Rp.: Followed by the name of the drug pundit a capital letter in the genitive case, Endomyocardial Fibrosis amount in one bottle in grams or units of action. At the opening of ampoules of content becomes sterile, so these dosage forms are intended for single use. The second line - DtdN in ampullis (Dai such doses number of items in capsules). Next, write Mflinimentun (mixing to make a liniment). Distinguish starch (wafers) and gelatin capsules. After the designation of Rp.: The name of the dosage form in the genitive singular with a capital letter (Linimenti), then the name of the drug with a capital Hemoglobin in the nominative case in quotes, pundit the Retino-binding Protein number of liniment in ml. For this purpose, ampoules and vials. The second line - DtdN in ampullis (Give the number of doses in capsules). Alcohol solution is not injected subcutaneously. Liquid extracts Cerebral Palsy colored liquid.